JAGX

SEC filing JAGX Regains Nasdaq Compliance, Subject to Mandatory Panel Monitor Until May 2027

6d ago

News Jaguar Health GAAP EPS of -$13.60, revenue of $20.27M

12d ago

SEC filing JAGX Q1 2026 Revenue $20.3M, Net Loss $7.0M, EPS -$13.60

12d ago

SEC filing JAGX Issues 908 Series Q Preferred Shares, Exchanges $22.6M Royalty Interest for Equity

13d ago

News Jaguar Health issues shares to reduce royalty debt - Investing.com

14d ago

SEC filing JAGX Regains Publicly Held Shares Compliance, Receives Nasdaq Extension

25d ago

SEC filing JAGX Post Reverse Split: 401K Public Shares, $1.00 Bid Price Issue, 513K Shares Outstanding, Awaits Nasdaq Compliance Confirmation

28d ago

SEC filing JAGX Delisted: Post-35:1 Reverse Split Leaves 401K Shares Below Nasdaq 500K Requirement, $1 Bid Price at Risk, May 8 Panel Hearing Deadline

29d ago

SEC filing JAGX Amends COI to Boost Authorized Shares to 500M, Stockholders Approve 6.03M For vs 1.13M Against

42d ago

SEC filing JAGX Stockholders' Equity Surpasses $2.5M via $16M Napo Capital, $3M Termination Gain, $1.2M Mytesi Sales

53d ago

SEC filing JAGX Amends Royalty Payments, Extends Debt Maturities, Terminates Warrants

85d ago

SEC filing JAGX Declares 1/10 Share Series O Preferred Stock Dividend, Files Certificate of Designation for 1,557,000 Shares

91d ago

News Bitcoin ETF suffers worst decline in over a year — and new investors are now sitting on ugly losses

116d ago

News Jaguar Land Rover Parent Posts Loss as Cyberattack Pain Lingers

117d ago

News Jaguar Mining reports Q4 results

138d ago

News UK Factory Output Grows as Sector Shakes Off Tax Concerns

150d ago